Acute Urticaria in a Young Female with COVID-19

Main Article Content

Rohit Kakar
Not applicable

Naissan Wesley
Skin Care and Laser Physicians of Beverly Hills, Los Angeles, CA Department of Medicine, Division of Dermatology, University of California, Los Angeles, Los Angeles, California

Keywords

urticaria, COVID-19, coronavirus

Abstract

This is the first known case of a young female (18 years old) with widespread urticaria amid active Covid-19 infection at a drive-up testing facility. Covid-19 should currently be on the differential diagnosis for urticaria seen in both the inpatient and outpatient setting. 

References

1. Henry D, Ackerman M, Sancelme E, Finon A, Esteve E. Urticarial eruption in COVID-19 infection. J Eur Acad Dermatol Venereol. 2020 Apri 15. Epub ahead of print.

2. van Damme C, Berlingin E, Saussez S, Accaputo O. Acute urticaria with pyrexia as the first manifestation of a COVID-19 infection. J Eur Acad Dermatol Venereol. 2020 Apr 24. Epub ahead of print.

3. Zuberbier T, Ifflander J, Semmler C, Henz BM. Acute urticaria: clinical aspects and therapeutic responsiveness. Acta Derm Venereol. 1996;76:295-297.

4. Imbalzano E, Casciaro M, Quartuccio S, Minciullo PL, Cascio A, Calapai G, Gangemi S. Association between urticaria and virus infections: A systemic review. Allergy Asthma Proc. 2016(1):18-22.

5. Kasperska-Zajac A, Sztylc J, Machura E, Jop G. Plasma IL-6 concentration correlates with clinical disease activity and serum C-reactive protein concentration in chronic urticaria patients. Clin Exp Allergy 2011(41): 1386-91

6. Aziz M, Fatima R, Assaly R. Elevated Interleukin-6 and Severe COVID-19: A Meta-Analysis. J Med Virol. 2020 Apr 28. Epub ahead of print.

Article Sidebar

PDF
Published
Jul 12, 2020
DOI https://doi.org/10.25251/skin.4.4.8

Article Details

How to Cite
Kakar, R., & Wesley, N. (2020). Acute Urticaria in a Young Female with COVID-19. SKIN The Journal of Cutaneous Medicine, 4(4), 337–339. https://doi.org/10.25251/skin.4.4.8
Issue
Vol. 4 No. 4 (2020)
Section
COVID Concepts
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.